Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort.
Nom du journal : Breast Cancer
Année : 2023
Volume : 30
Page de départ : 329-341
